Process Mapping and Data Collection to Inform a Computer Simulation Model of Hospitalised Patients With Bloodstream Infection, Sepsis and Systemic Infection
Launched by LIVERPOOL UNIVERSITY HOSPITALS NHS FOUNDATION TRUST · Feb 14, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial aims to create a computer simulation to better understand how different healthcare policies and resources impact the treatment of patients with bloodstream infections, sepsis, and systemic infection. By gathering information through interviews with healthcare staff and analyzing past data on infections and antibiotic treatments, the study hopes to help doctors and healthcare leaders make informed decisions. This is important because it can lead to better patient care and help prevent the overuse of antibiotics, which can make infections harder to treat.
To participate in this trial, you need to be at least 18 years old and have been treated at a specific hospital for a bloodstream infection. The study will not involve any new treatments; instead, it will observe how patients are currently treated and gather feedback from the medical staff involved in their care. If you're eligible, you may be asked for your insights, but your participation is entirely observational, meaning you won’t receive any experimental treatments as part of this trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Sub-study 2 (retrospective data collection)
- • Patients who were managed within a LUFT acute hospital site (Aintree or Royal) and had a concurrent blood culture investigation requested
- • Age ≥ 18 years at the time of the study. Sub-study 3 (observational study)
- • Patients with blood culture investigation requested during the observation period, and staff caring for the patients.
- Exclusion Criteria:
- • Age \< 18 years at the time of the study
- • Blood culture requested but patient not managed on an acute hospital site.
About Liverpool University Hospitals Nhs Foundation Trust
Liverpool University Hospitals NHS Foundation Trust is a leading healthcare organization in the UK, dedicated to providing high-quality patient care, advancing medical research, and fostering education in the health sciences. With a strong commitment to innovation and excellence, the Trust actively participates in clinical trials aimed at improving treatment outcomes and enhancing healthcare delivery. By collaborating with academic institutions and industry partners, Liverpool University Hospitals NHS Foundation Trust strives to bridge the gap between research and clinical practice, ensuring that cutting-edge therapies and interventions are accessible to patients in the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Liverpool, , United Kingdom
Patients applied
Trial Officials
Alessandro D Gerada
Principal Investigator
University of Liverpool
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported